~~<i id='62644A10CF'><strike id='62644A10CF'><tt id='62644A10CF'><pre id='62644A10CF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：hotspot 2025-09-30 18:59:30 - browse：9613

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： South Korea throws huge K

explore

hotspot

entertainment

focus

1:30Aboywalksthroughafloodedareainal-SagainorthofOmdurmanonAugust6,2023.Torrentialrainshavedestroyed

WSS

Listen: Your guide to Wegovy's blockbuster heart study

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Why failed clinical trials don’t always spell doom for a new drug

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Kim Kardashian sparks debate on benefits of full

Friends ask where James Watson's attitudes about race came from

entertainment

entertainment

explore

23andMe had bad news about my health. I wish a person had delivered it

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Medical leaders decry Supreme Court decision on affirmative action

Maui's cultural, historic landmarks damaged in the devastating wildfires

Tori Bowie and the unacceptable rates of Black maternal death

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

The high cost of giving birth even with insurance

Covid's long

What does generative AI mean for health care? We asked experts

American woman, child freed after being kidnapped in Haiti last month

hotspot

Why failed clinical trials don’t always spell doom for a new drug

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

White House drug shortages task force keeps mum with Congress

hotspot

entertainment

entertainment

focus